ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் துறை ஆஃப் மனநல மருத்துவம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் துறை ஆஃப் மனநல மருத்துவம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் துறை ஆஃப் மனநல மருத்துவம் Today - Breaking & Trending Today

Coronavirus infection more likely to cause blood clots than vaccines: New Oxford study


Last Updated:
Coronavirus Infection More Likely To Cause Blood Clots Than Vaccines: New Oxford Study
The latest study by Oxford University says that the rare blood clot is caused majorly by Coronavirus infection & the risk post-vaccine is lesser than the virus.
Credits: OXFORD/TWITTER/AP/UNSPLASH/REPRESENTATIVE IMAGE
The University of Oxford has published its latest findings on rare blood clot risks which are caused post-COVID-19 infection and it is much more severe than the post-vaccine effect. The study shows that the rare blood clot is 100 times more harmful than normal and several times more dangerous than after vaccination. The rare blood clot is found to be Cerebral Venous Thrombosis (CVT) which is common following the infection. The under-30 age group has seen 30 per cent of such cases.  ....

Paul Harrison , Oxford Astrazeneca , Maxime Taquet , University Of Oxford , Oxford University Department Of Psychiatry , Oxford Health Biomedical Research Centre , Cerebral Venous Thrombosis , Professor Harrison , Oxford University , Health Biomedical Research Centre , பால் ஹாரிசன் , பல்கலைக்கழகம் ஆஃப் ஆக்ஸ்ஃபர்ட் , ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் துறை ஆஃப் மனநல மருத்துவம் , ஆக்ஸ்ஃபர்ட் ஆரோக்கியம் உயிர் மருத்துவ ஆராய்ச்சி மையம் , சிஇஆர்இபிஆர்ஏஎல் சிரை த்ரோம்போசிஸ் , ப்ரொஃபெஸர் ஹாரிசன் , ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் , ஆரோக்கியம் உயிர் மருத்துவ ஆராய்ச்சி மையம் ,

Rare blood clotting risk more for COVID-19 than for vaccines: Oxford study


Rare blood clotting risk more for COVID-19 than for vaccines: Oxford study
Rare blood clotting risk more for COVID-19 than for vaccines: Oxford study
After contracting Covid-19 the risk of blood clotting is much greater than it is post immunisation according to Oxford University study.
advertisement
(Representative image: Reuters)
The risk of rare blood clotting following the Covid-19 infection is around 100 times greater than normal, several times higher than it is post-vaccination or following influenza, according to a new University of Oxford study published on Thursday.
The research found that the rare blood clotting known as Cerebral Venous Thrombosis (CVT) is more common after Covid-19 than in any of the comparison groups, with 30 per cent of these cases occurring in the under 30s. ....

United Kingdom , Paul Harrison , Oxford Astrazeneca , Maxime Taquet , Oxford Astrazeneca Covid , University Of Oxford , Head Of The Translational Neurobiology Group , Oxford University Department Of Psychiatry , Oxford Health Biomedical Research Centre , Translational Neurobiology Group , Regulatory Agency , World Health Organisation , Cerebral Venous Thrombosis , Professor Harrison , Oxford University , Health Biomedical Research Centre , Translational Neurobiology , Covid 19 , Covid Vaccine , Oxford University , Cerebral Venous Thrombosis , ஒன்றுபட்டது கிஂக்டம் , பால் ஹாரிசன் , பல்கலைக்கழகம் ஆஃப் ஆக்ஸ்ஃபர்ட் , ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் துறை ஆஃப் மனநல மருத்துவம் , ஆக்ஸ்ஃபர்ட் ஆரோக்கியம் உயிர் மருத்துவ ஆராய்ச்சி மையம் ,

The FINANCIAL - Risk of rare blood clotting higher for COVID-19 than for vaccines


Share This
The FINANCIAL COVID-19 leads to a several-times higher risk of cerebral venous thrombosis (CVT) blood clots than current COVID-19 vaccines. Researchers at the University of Oxford have today reported that the risk of the rare blood clotting known as cerebral venous thrombosis (CVT) following COVID-19 infection is around 100 times greater than normal, several times higher than it is post-vaccination or following influenza, University of Oxford notes.
The study authors, led by Professor Paul Harrison and Dr Maxime Taquet from Oxford University’s Department of Psychiatry and the NIHR Oxford Health Biomedical Research Centre, counted the number of CVT cases diagnosed in the two weeks following diagnosis of COVID-19, or after the first dose of a vaccine. The then compared these to calculated incidences of CVT following influenza, and the background level in the general population. ....

Paul Harrison , Maxime Taquet , University Of Oxford , Head Of The Translational Neurobiology Group , Oxford University Department Of Psychiatry , Oxford Health Biomedical Research Centre , Translational Neurobiology Group , Professor Paul Harrison , Oxford University , Health Biomedical Research Centre , The Financial Covid 19 Leads Toa Several Times Higher Risk Of Cerebral Venous Thrombosis Cvt Blood Clots Than Current Vaccines Researchers At University Oxford Have Today Reported That Rare Clotting Known As Following Infection Is Around 100 Greater Normal , Everal Times Higher Than It Is Post Vaccination Or Following Influenza , Niversity Of Oxford Notes , பால் ஹாரிசன் , பல்கலைக்கழகம் ஆஃப் ஆக்ஸ்ஃபர்ட் , ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் துறை ஆஃப் மனநல மருத்துவம் , ஆக்ஸ்ஃபர்ட் ஆரோக்கியம் உயிர் மருத்துவ ஆராய்ச்சி மையம் , ப்ரொஃபெஸர் பால் ஹாரிசன் , ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் , ஆரோக்கியம் உயிர் மருத்துவ ஆராய்ச்சி மையம் ,